CKS1BP7

Across TCGA pan-cancer cohorts, CKS1BP7 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated CKS1BP7 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher CKS1BP7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CKS1BP7 expression acts as an unfavorable survival marker, although some lineages such as KIRC and BLCA show a favorable association.

UVM, ACC, and KIRC are the cancer types where CKS1BP7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Quartile	All	0.369	0.707	<.001	66	view →
ACC	DFS	Median	All	0.261	0.612	<.001	63	view →
KIRC	DFS	Median	III,IV	0.793	0.474	<.001	56	view →
KICH	DFS	Tertile	II,III,IV	0.365	0.937	.001	35	view →
PAAD	OS	Quartile	All	0.232	0.491	.004	22	view →
BLCA	OS	Quartile	III,IV	0.557	0.139	.006	16	view →
HNSC	OS	Quartile	II,III,IV	0.857	0.708	.002	16	view →
OV	OS	Quartile	All	0.607	0.716	.032	14	view →
LIHC	OS	Tertile	III,IV	0.290	0.632	.002	11	view →
THYM	DFS	Tertile	IV	0.407	1.000	.026	9	view →
LUSC	DFS	Median	II,III,IV	0.364	0.632	.022	9	view →
SARC	DFS	Quartile	All	0.472	0.639	.010	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

CKS1BP7–UVM (DFS)

Open the UVM breakdown →